Genetic test that combines the study of allelic variants in metabolising genes (only Phase I), transporters and targets to provide relevant information on possible adverse reactions or the possibility of therapeutic responses.
Which patients is it most useful for?
DrugChip® offers a study of over 70 frequently used drugs related to these main conditions:
- Neuropsychiatric disorders
- Anxiety and insomnia
- Cardiovascular disease
Select the most appropriate drugs using the genetic information to:
Minimise side effects
Maximise therapeutic efficacy
What information does it provide?
DrugChip® analyses the two main groups of genes involved in:
PHARMACODYNAMIC PROPERTIES OF DRUGS
- How the drug acts on our body.
- Determine the efficacy of the drug.
PHARMACOKINETIC PROPERTIES OF DRUGS
- How the body modifies the drug.
- Determine the toxicity of the drug.